Andy Yu
As the founder of Meowsprout Therapeutics, Andy is dedicated to revolutionizing medicine and care for neurodiverse individuals. Our mission is to create a world where behavioral and neuro-disorders, such as ADHD and ASD, are no longer barriers to achieving life goals.
At TMFOX, his role as Managing Partner involves steering over 600 global clients through strategic growth, product insights, and over 1 billion USD in funding, leveraging expertise in Mergers & Acquisitions and business planning.
The journey through TMFOX and Meowsprout has been marked by a commitment to integrating cutting-edge technologies with strategic business development. We aim to reduce uncertainties in high-tech ventures and healthcare innovation by fostering global collaboration. Andy’s mission revolves around empowering entrepreneurs and ensuring the success of our clients by providing holistic solutions and insights for their worldwide expansion and market positioning.
